Publications by authors named "P Schlagenhauf"
Article Synopsis
- * Two vaccines are available: Dengvaxia®, which is not recommended for travelers, and Qdenga®, which is now licensed for travelers in several European countries, including Switzerland.
- * The Swiss Expert Committee for Travel Medicine advises that Qdenga® should not be given to those without prior dengue infection, but may be suitable for travelers aged 6 and older who have proof of past infection and are going to areas with high dengue transmission.
Background: Although the recent literature indicates that mpox (monkeypox) primarily affects men, there are also multiple reports in women. Estimates of the sex distribution of mpox patients and patterns will enable a better understanding of the ongoing mpox outbreak.
Methods: In this systematic review and meta-analysis, seven databases were searched for studies published in English up to January 4, 2023.